BETH ISRAEL DEACONESS MEDICAL CENTER

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Established: 1896-01-01

Employees: -

Market Cap: -

Website: https://www.bidmc.org/

Clinical Trials

Arterial Spin Labeling Blood Flow Magnetic Resonance Imaging for the Evaluation of Response to Therapy in Metastatic Renal Cell Carcinoma

Not Applicable

Terminated

Conditions: Renal Cell Carcinoma

Interventions: Procedure: Arterial Spin Labeling Blood Flow Magnetic Resonance Imaging

First Posted Date: 2009-08-06

Last Posted Date: 2020-06-30

Lead Sponsor: Beth Israel Deaconess Medical Center

Target Recruit Count: 2

Registration Number: NCT00953446

Locations: 🇺🇸
Dana-Farber Cancer Institute, Boston, Massachusetts, United States
🇺🇸
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States

Objective Flap Assessment During Reconstructive Surgery

Early Phase 1

Completed

Conditions: Cancer

Interventions: Device: FLARE imaging system

First Posted Date: 2009-08-04

Last Posted Date: 2012-06-13

Lead Sponsor: Beth Israel Deaconess Medical Center

Target Recruit Count: 6

Registration Number: NCT00952107

Locations: 🇺🇸
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States

Serum Markers in Gluten Challenge

Not Applicable

Completed

Conditions: Celiac Disease

Interventions: Dietary Supplement: Gluten

First Posted Date: 2009-07-02

Last Posted Date: 2021-06-04

Lead Sponsor: Beth Israel Deaconess Medical Center

Target Recruit Count: 21

Registration Number: NCT00931892

Locations: 🇺🇸
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States

Exercise Program in Women With Metabolic Syndrome

Not Applicable

Completed

Conditions: Metabolic Syndrome

Interventions: Behavioral: MAST program

First Posted Date: 2009-06-29

Last Posted Date: 2017-11-13

Lead Sponsor: Beth Israel Deaconess Medical Center

Target Recruit Count: 28

Registration Number: NCT00929500

Locations: 🇺🇸
Beth Israel Deaconess Medical Center, Harvard University, Boston, Massachusetts, United States

The Use of Transcranial Direct Current Stimulation (TDCS) to Enhance the Rehabilitative Effect of Vision Restoration Therapy

Early Phase 1

Completed

Conditions: Hemianopia
Quadrantanopia
Scotoma
Visual Field Loss

Interventions: Behavioral: Vision Restoration Therapy (VRT)
Device: Transcranial direct current stimulation (tDCS)

First Posted Date: 2009-06-16

Last Posted Date: 2012-03-21

Lead Sponsor: Beth Israel Deaconess Medical Center

Target Recruit Count: 20

Registration Number: NCT00921427

Enoxaparin Thromboprophylaxis in Cancer Patients With Elevated Tissue Factor Bearing Microparticles

Phase 2

Completed

Conditions: Advanced Pancreatic, Colon, Lung, Gastric and Ovarian Cancer

Interventions: Drug: Enoxaparin

First Posted Date: 2009-05-27

Last Posted Date: 2017-12-19

Lead Sponsor: Beth Israel Deaconess Medical Center

Target Recruit Count: 70

Registration Number: NCT00908960

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States
🇺🇸
University of Southern California-Keck School of Medicine, Los Angeles, California, United States
🇺🇸
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States

and more 2 locations

Self-guided Depression Treatment on Long-duration Spaceflights: A Continuation Study

Not Applicable

Completed

Conditions: Depression

Interventions: Behavioral: Computer-based Problem-Solving Treatment

First Posted Date: 2009-05-21

Last Posted Date: 2017-04-13

Lead Sponsor: Beth Israel Deaconess Medical Center

Target Recruit Count: 68

Registration Number: NCT00906581

Locations: 🇺🇸
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States

Melodic-Intonation-Therapy and Speech-Repetition-Therapy for Patients With Non-fluent Aphasia

Phase 3

Completed

Conditions: Stroke
Apoplexy
Cerebral Infarction
Aphasia
Cerebrovascular Accident

Interventions: Behavioral: Melodic Intonation Therapy
Behavioral: Speech-Repetition-Therapy

First Posted Date: 2009-05-18

Last Posted Date: 2020-09-21

Lead Sponsor: Beth Israel Deaconess Medical Center

Target Recruit Count: 30

Registration Number: NCT00903266

Locations: 🇺🇸
Beth Israel Deaconess Medical Center / Harvard Medical School, Boston, Massachusetts, United States

Avastin in Patients With Epithelial Ovarian, Primary Peritoneal Serous or Fallopian Tube Cancer

Phase 2

Terminated

Conditions: Primary Peritoneal Serous Cancer
Fallopian Tube Cancer
Ovarian Cancer

Interventions: Drug: bevacizumab

First Posted Date: 2009-03-20

Last Posted Date: 2018-05-22

Lead Sponsor: Beth Israel Deaconess Medical Center

Target Recruit Count: 5

Registration Number: NCT00866723

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States
🇺🇸
Dana-Farber Cancer Institute, Boston, Massachusetts, United States
🇺🇸
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States

Characterization of Prostate Cancer With 3T MR

Active, not recruiting

Conditions: Prostate Cancer

First Posted Date: 2009-01-28

Last Posted Date: 2024-04-26

Lead Sponsor: Beth Israel Deaconess Medical Center

Target Recruit Count: 236

Registration Number: NCT00831142

Locations: 🇺🇸
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy